Paul N. Reynolds

11.8k total citations · 1 hit paper
174 papers, 7.6k citations indexed

About

Paul N. Reynolds is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Paul N. Reynolds has authored 174 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 50 papers in Physiology and 46 papers in Molecular Biology. Recurrent topics in Paul N. Reynolds's work include Asthma and respiratory diseases (34 papers), Transplantation: Methods and Outcomes (28 papers) and Virus-based gene therapy research (28 papers). Paul N. Reynolds is often cited by papers focused on Asthma and respiratory diseases (34 papers), Transplantation: Methods and Outcomes (28 papers) and Virus-based gene therapy research (28 papers). Paul N. Reynolds collaborates with scholars based in Australia, United States and United Kingdom. Paul N. Reynolds's co-authors include Sandra Hodge, Mark Holmes, Greg Hodge, David T. Curiel, Hubertus Jersmann, John W. Upham, Ian A. Yang, Peter G. Gibson, Jodie L. Simpson and Jessica Ahern and has published in prestigious journals such as The Lancet, Nature Biotechnology and PLoS ONE.

In The Last Decade

Paul N. Reynolds

166 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

2017 446 citations Peter G. Gibson, Ian A. Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul N. Reynolds Australia	46	3.4k	2.5k	2.3k	1.8k	1.5k	174	7.6k
Francis X. McCormack United States	54	5.3k 1.6×	1.8k 0.7×	3.9k 1.7×	1.5k 0.8×	464 0.3×	201	9.9k
Farrah Kheradmand United States	45	2.6k 0.8×	1.9k 0.8×	2.4k 1.0×	2.0k 1.1×	264 0.2×	142	7.7k
Kenji Izuhara Japan	55	2.3k 0.7×	1.4k 0.6×	3.9k 1.7×	3.2k 1.8×	315 0.2×	239	9.1k
Caroline A. Owen United States	43	3.3k 1.0×	1.6k 0.7×	1.2k 0.5×	1.2k 0.7×	297 0.2×	123	6.6k
Johan Grünewald Sweden	55	5.2k 1.6×	2.4k 1.0×	5.3k 2.2×	2.3k 1.3×	318 0.2×	269	11.3k
Tomoaki Hoshino Japan	45	2.6k 0.8×	2.3k 0.9×	1.1k 0.5×	2.7k 1.5×	287 0.2×	248	7.7k
Tomoko Betsuyaku Japan	46	3.9k 1.2×	2.0k 0.8×	1.7k 0.7×	1.6k 0.9×	142 0.1×	254	8.1k
Susetta Finotto Germany	36	717 0.2×	1.1k 0.5×	1.6k 0.7×	3.1k 1.7×	683 0.5×	121	5.8k
Robert Vassallo United States	47	3.4k 1.0×	745 0.3×	2.9k 1.3×	988 0.6×	232 0.2×	152	6.7k
Didier Cataldo Belgium	46	1.9k 0.6×	1.6k 0.7×	1.6k 0.7×	1.7k 0.9×	164 0.1×	119	6.2k

Countries citing papers authored by Paul N. Reynolds

Since Specialization

Citations

This map shows the geographic impact of Paul N. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul N. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul N. Reynolds more than expected).

Fields of papers citing papers by Paul N. Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul N. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul N. Reynolds. The network helps show where Paul N. Reynolds may publish in the future.

Co-authorship network of co-authors of Paul N. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Paul N. Reynolds. A scholar is included among the top collaborators of Paul N. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul N. Reynolds. Paul N. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mackintosh, John A., Marc Sylva, Lucio Calandriello, et al.. (2026). Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis. Respirology.

Yang, Nan, Francesco Federico, Stephen M. Humphries, et al.. (2025). Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. European Respiratory Journal. 66(4). 2500981–2500981.

Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations

Mackintosh, John A., Gregory J. Keir, Lauren Troy, et al.. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 29(2). 105–135. 26 indexed citations

Hodge, Greg, et al.. (2023). BLTR1 Is Decreased in Steroid Resistant Pro-inflammatory CD28nullCD8+ T Lymphocytes in Patients With COPD: The Spillover Hypothesis Explained?. A4808–A4808.

Hodge, Greg, et al.. (2022). COPD is associated with increased pro-inflammatory CD28null CD8 T and NKT-like cells in the small airways. Clinical & Experimental Immunology. 207(3). 351–359. 8 indexed citations

Tran, Hai B., et al.. (2021). Dysregulated zinc and sphingosine‐1‐phosphate signaling in pulmonary hypertension: Potential effects by targeting of bone morphogenetic protein receptor type 2 in pulmonary microvessels. Cell Biology International. 45(11). 2368–2379. 9 indexed citations

O’Neill, Ciarán, Peter G. Gibson, Liam G. Heaney, et al.. (2020). The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma. European Respiratory Journal. 57(2). 2002436–2002436. 4 indexed citations

Harper, Rebecca L., et al.. (2019). BMPR2‐expressing bone marrow‐derived endothelial‐like progenitor cells alleviate pulmonary arterial hypertension in vivo. Respirology. 24(11). 1095–1103. 23 indexed citations

10.

Taylor, Steven, Lex E. X. Leong, Fredrick M. Mobegi, et al.. (2019). Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma. American Journal of Respiratory and Critical Care Medicine. 200(3). 309–317. 128 indexed citations

11.

Gibson, Peter G., Ian A. Yang, John W. Upham, et al.. (2017). Azithromycin Reduces Exacerbations In Adults With Persistent Symptomatic Eosinophilic Asthma. Respirology. 195. 24–24. 1 indexed citations

12.

Jersmann, Hubertus, et al.. (2016). The Effect of Colonization with Potentially Pathogenic Microorganisms on Efferocytosis in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 194(7). 912–915. 9 indexed citations

13.

Simpson, Jodie L., Ian A. Yang, John W. Upham, et al.. (2015). Sputum and serum periostin levels are associated with, but do not predict sputum eosinophil proportion in severe asthma. American Journal of Respiratory and Critical Care Medicine. 191. 2 indexed citations

14.

Zhang, Xin, Jodie L. Simpson, Heather Powell, et al.. (2014). Full blood count parameters for the detection of asthma inflammatory phenotypes. Clinical & Experimental Allergy. 44(9). 1137–1145. 177 indexed citations

15.

Hodge, Greg, Mark Holmes, Hubertus Jersmann, Paul N. Reynolds, & Sandra Hodge. (2014). Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD. BMC Pulmonary Medicine. 14(1). 85–85. 12 indexed citations

16.

Simpson, Joe Leigh, Ian A. Yang, Paul N. Reynolds, et al.. (2013). Alternatives to Induced Sputum for Identifying Patients with Eosinophilic Asthma. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 2 indexed citations

17.

Morecroft, Ian, Paola Caruso, Margaret Nilsen, et al.. (2012). AH MacLean MR. Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension. Molecular Imaging and Radionuclide Therapy. 20. 1516–1528. 3 indexed citations

18.

Hodge, Sandra, Greg Hodge, Hubertus Jersmann, et al.. (2008). Azithromycin Improves Macrophage Phagocytic Function and Expression of Mannose Receptor in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 178(2). 139–148. 196 indexed citations

19.

Breidenbach, Martina, Daniel Rein, Thomas Schöndorf, et al.. (2005). A new targeting approach for breast cancer gene therapy using the Heparanase promoter. Cancer Letters. 240(1). 114–122. 17 indexed citations

20.

Reynolds, Paul N. & David T. Curiel. (1999). 6 Strategies to Adapt Adenoviral Vectors for Gene Therapy Applications: Targeting and Integration. Cold Spring Harbor Monograph Archive. 36. 111–130. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact